Real life experience of usage of vildagliptin versus sulfonylurea therapy in fasting patients with type 2 diabetes during Ramadan: an Indian experience

被引：0
|
作者：
Shete, A. V. V. [1 ]
机构：
[1] Novartis India Ltd, Mumbai, Maharashtra, India
来源：
DIABETOLOGIA | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
840
引用
收藏
页码：S342 / S343
页数：2
相关论文
共 50 条
  • [1] Vildagliptin vs sulfonylurea in Indian Muslim diabetes patients fasting during Ramadan
    Shete, Abhijit
    Shaikh, Aheson
    Nayeem, K. Javeed
    Rodrigues, Lily
    Ali, Mohamed Sheikamunadeen Sadiq
    Shah, Parag
    Khanna, Rajiv
    Majid, Sarfaraj
    Rasheed, Sabeer A.
    Shaikh, Shehla
    Rahman, Tawfiqur
    WORLD JOURNAL OF DIABETES, 2013, 4 (06): : 358 - 364
  • [2] Effect of Vildagliptin Versus Sulfonylurea in Muslim Patients with Type 2 Diabetes Fasting During Ramadan in Egypt: Results from VIRTUE Study
    Mohamed Khattab
    Khalifa Mahmoud
    Inass Shaltout
    Diabetes Therapy, 2016, 7 : 551 - 560
  • [3] Effect of Vildagliptin Versus Sulfonylurea in Muslim Patients with Type 2 Diabetes Fasting During Ramadan in Egypt: Results from VIRTUE Study
    Khattab, Mohamed
    Mahmoud, Khalifa
    Shaltout, Inass
    DIABETES THERAPY, 2016, 7 (03) : 551 - 560
  • [4] Fasting experience of patients with Type 2 diabetes mellitus on insulin therapy during Ramadan: VISION Ramadan substudy
    Jabbar, Abdul
    Mohamed, Wan Mohd Izani Wan
    Spaepen, Erik
    Reed, Victoria
    Tayeb, Khaled
    Khalil, Samir H. Assaad
    Treuer, Tamas
    Bhattacharya, Indranil
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 151 : 285 - 289
  • [5] Experience with Vildagliptin in Type 2 Diabetic Patients Fasting During Ramadan in France: Insights from the VERDI Study
    Serge Halimi
    Marc Levy
    Dominique Huet
    Stéphane Quéré
    Sylvie Dejager
    Diabetes Therapy, 2013, 4 : 385 - 398
  • [6] Experience with Vildagliptin in Type 2 Diabetic Patients Fasting During Ramadan in France: Insights from the VERDI Study
    Halimi, Serge
    Levy, Marc
    Huet, Dominique
    Quere, Stephane
    Dejager, Sylvie
    DIABETES THERAPY, 2013, 4 (02) : 385 - 398
  • [7] Vildagliptin therapy and hypoglycaemia in Muslim type 2 diabetes patients during Ramadan
    Devendra, D.
    Gohel, B.
    Bravis, V.
    Hui, E.
    Salih, S.
    Mehar, S.
    Hassanein, M.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (10) : 1446 - 1450
  • [8] The effect of vildagliptin relative to sulfonylurea as dual therapy with metformin (or as monotherapy) in Muslim patients with type 2 diabetes fasting during Ramadan in the Middle East: the VIRTUE study
    Hassoun, Ahmed A. K.
    Al-Arouj, Monira
    Ibrahim, Mohamed
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (01) : 161 - 167
  • [9] Experience with DPP-4 inhibitors in the management of patients with type 2 diabetes fasting during Ramadan
    Schweizer, Anja
    Halimi, Serge
    Dejager, Sylvie
    VASCULAR HEALTH AND RISK MANAGEMENT, 2014, 10 : 15 - 24
  • [10] Glycemic effects of vildagliptin in patients with type 2 diabetes before, during and after the period of fasting in Ramadan
    Malha, Line P.
    Taan, Ghazi
    Zantout, Mira S.
    Azar, Sami T.
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2014, 5 (01) : 3 - 9
12345